Rethinking Cardiovascular Risk in Europe
Welcome to Amarin
Amarin Corporation plc is a rapidly growing, innovative pharmaceutical company focused on developing and commercializing therapeutics to cost-effectively improve cardiovascular health.
Here you will find our latest European press releases and media contact details
The European Commission gives green light to a proven new treatment to reduce cardiovascular events such as heart attacks, strokes and cardiac deaths
For general enquires and requests for further information, please email us at [email protected]